- Home
- Publications
- Publication Search
- Publication Details
Title
Physiological effects of modulating the interleukin-6 axis
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 57, Issue suppl_2, Pages ii43-ii50
Publisher
Oxford University Press (OUP)
Online
2018-01-27
DOI
10.1093/rheumatology/kex513
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunogenicity of tocilizumab in patients with rheumatoid arthritis
- (2017) Johanna Sigaux et al. JOINT BONE SPINE
- Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study
- (2016) EL Kneepkens et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients
- (2015) Javier Loricera et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
- (2014) Shunsuke Mori et al. CLINICAL RHEUMATOLOGY
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy
- (2014) Toshio Tanaka et al. SEMINARS IN IMMUNOLOGY
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- The Biology and Medical Implications of Interleukin-6
- (2014) T. Tanaka et al. Cancer Immunology Research
- Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure
- (2013) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Immune mechanisms in medium and large-vessel vasculitis
- (2013) Cornelia M. Weyand et al. Nature Reviews Rheumatology
- Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis
- (2013) Tsuyoshi Kasama et al. RHEUMATOLOGY INTERNATIONAL
- Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities
- (2013) Jürgen Scheller et al. SEMINARS IN IMMUNOLOGY
- Brief Report: Inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
- (2012) Maxime Samson et al. ARTHRITIS AND RHEUMATISM
- Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients
- (2012) B. Pesce et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- The origins, function, and regulation of T follicular helper cells
- (2012) Cindy S. Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica
- (2012) S. Unizony et al. ARTHRITIS CARE & RESEARCH
- Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
- (2011) Shun Kitaba et al. AMERICAN JOURNAL OF PATHOLOGY
- Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis
- (2011) C. Beyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Therapeutic Targeting of the Interleukin-6 Receptor
- (2011) Toshio Tanaka et al. Annual Review of Pharmacology and Toxicology
- In vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment
- (2011) Petra Roll et al. ARTHRITIS AND RHEUMATISM
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- Integrated safety in tocilizumab clinical trials
- (2011) Michael H Schiff et al. ARTHRITIS RESEARCH & THERAPY
- Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease
- (2010) S.-N. J. Song et al. BLOOD
- Interleukin-6 Signaling in Liver-Parenchymal Cells Suppresses Hepatic Inflammation and Improves Systemic Insulin Action
- (2010) F. Thomas Wunderlich et al. Cell Metabolism
- Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing
- (2010) Kay Stubenrauch et al. CLINICAL THERAPEUTICS
- Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
- (2010) V. B. Matthews et al. DIABETOLOGIA
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
- (2010) Shigeru Kotake et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A
- (2009) Naoko Okiyama et al. ARTHRITIS AND RHEUMATISM
- Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses
- (2008) Minoru Fujimoto et al. ARTHRITIS AND RHEUMATISM
- Gut, inflammation and osteoporosis: basic and clinical concepts
- (2008) H. Tilg et al. GUT
- IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
- (2008) Satoshi Serada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-6 regulates pancreatic -cell mass expansion
- (2008) H. Ellingsgaard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- and IL-17
- (2008) M. Hashizume et al. RHEUMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started